Alcon Inc. (NYSE:ALC) is reporting third quarter earnings results on Tuesday 10th November 2020, after market close.
The consensus estimates from Thomson Reuters are income of $ 0.22 per share.
For the full year, analysts predict revenues of $ 6561.39 million, while looking forward to income of $ 0.89 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 7,730.00 million ~ $ 7,804.00 million, where as bottomline are predicted in a range of $ 1.95 ~ $ 2.05 per share
Click Here For More Historical Outlooks Of Alcon Inc.
Previous Quarter Performance
Alcon Inc. reported loss for the second quarter of $ 0.21 per share, from the revenue of $ 1,198.00 million. The quarterly revenues shrunk 35.70 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.15 per share from $ 1136.96 million in revenue. The bottom line results missed street analysts by $ 0.06 or 40 percent, at the same time, top line results outshined analysts by $ 61.04 million or 5.37 percent.
Stock Performance
Shares of Alcon Inc. traded up $ 2.67 or 4.24 percent on Monday, reaching $ 65.63 with volume of 1.99 million shares. Alcon Inc. has traded high as $ 68.11 and has cracked $ 65.60 on the downward trend
According to the previous trading day, closing price of $ 65.63, representing a 59.92 % increase from the 52 week low of $ 39.37 and a 7.56 % decrease over the 52 week high of $ 68.11.
The company has a market capital of $ 32.00 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Alcon, Inc. develops and manufactures eye care products for eye care professionals and their patients. It offers surgical products, which include technologies and devices for cataract, retinal, glaucoma, and refractive surgery; advanced technology intraocular lenses to treat cataracts and refractive errors, such as presbyopia and astigmatism; and advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery.
